Existing flu vaccines provide only limited, “seasonal” protection because they target highly changeable proteins on the virus. Scripps Research scientists have now designed a vaccine that should work broadly against...
Duke Health is leading its first clinical trial under a large federal initiative to develop a new-generation flu vaccine. The phase 1 clinical trial, which launched last month, is testing the safety of a vaccine...
Influenza, commonly referred to as “flu”, is a major global public health concern and a huge economic burden to societies. Seasonal influenza epidemics afflict between 13 to 100 million individuals annually, including...